Modeling inducible human tissue neoplasia identifies an extracellular matrix interaction network involved in cancer progression.

[1]  R. Weinberg,et al.  Species- and cell type-specific requirements for cellular transformation. , 2004, Cancer cell.

[2]  A. Fraser,et al.  A single gene network accurately predicts phenotypic effects of gene perturbation in Caenorhabditis elegans , 2008, Nature Genetics.

[3]  Jason A. Reuter,et al.  Use of conditionally active ras fusion proteins to study epidermal growth, differentiation, and neoplasia. , 2006, Methods in enzymology.

[4]  Paul A. Bates,et al.  Global topological features of cancer proteins in the human interactome , 2006, Bioinform..

[5]  J. Ott,et al.  Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. , 2006, The Journal of investigative dermatology.

[6]  P. Marrack,et al.  The function of antigen-presenting cells in mice with severe combined immunodeficiency. , 1985, Journal of immunology.

[7]  E. Wayner,et al.  Regulation of human B-cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1) , 1993 .

[8]  F. Watt,et al.  New roles for integrins in squamous-cell carcinoma , 2006, Nature Reviews Cancer.

[9]  P. Khavari,et al.  Inducible activation of Ras and Raf in adult epidermis. , 2003, Cancer research.

[10]  M. Weinstock,et al.  Trends in nonmelanoma skin cancer mortality rates in the United States, 1969 through 2000. , 2005, The Journal of investigative dermatology.

[11]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Patrick O. Brown,et al.  Gene Expression Patterns in Pancreatic Tumors, Cells and Tissues , 2007, PloS one.

[13]  Paul A. Khavari,et al.  Modelling cancer in human skin tissue , 2006, Nature Reviews Cancer.

[14]  Howard Y. Chang,et al.  Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  W. Muller,et al.  Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. , 2004, Cancer cell.

[17]  John S. Condeelis,et al.  Identification and Testing of a Gene Expression Signature of Invasive Carcinoma Cells within Primary Mammary Tumors , 2004, Cancer Research.

[18]  Conditional ablation of beta1 integrin in skin. Severe defects in epidermal proliferation, basement membrane formation, and hair follicle invagination. , 2000, The Journal of cell biology.

[19]  Jennifer Y. Zhang,et al.  Tumor necrosis factor receptor 1/c-Jun-NH2-kinase signaling promotes human neoplasia. , 2007, Cancer research.

[20]  N. Fusenig,et al.  Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.

[21]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[22]  D. Bae,et al.  Expression profile of skin papillomas with high cancer risk displays a unique genetic signature that clusters with squamous cell carcinomas and predicts risk for malignant conversion , 2007, Oncogene.

[23]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[24]  Z. Werb,et al.  Coevolution of cancer and stromal cellular responses. , 2005, Cancer cell.

[25]  A. Barabasi,et al.  Lethality and centrality in protein networks , 2001, Nature.

[26]  J. Mesirov,et al.  An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis , 2005, Nature Genetics.

[27]  K. Gunsalus,et al.  Network modeling links breast cancer susceptibility and centrosome dysfunction. , 2007, Nature genetics.

[28]  J. Vandenbroucke,et al.  Incidence of skin cancer after renal transplantation in The Netherlands. , 1990, Transplantation.

[29]  F. Watt,et al.  Changes in the expression of αv integrins in oral squamous cell carcinomas , 1997 .

[30]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[31]  B. Ganter,et al.  Emerging applications of network and pathway analysis in drug discovery and development. , 2008, Current opinion in drug discovery & development.

[32]  P. Khavari,et al.  The Class II Phosphoinositide 3-Kinase C2β Is Not Essential for Epidermal Differentiation , 2005, Molecular and Cellular Biology.

[33]  Eran Segal,et al.  Module map of stem cell genes guides creation of epithelial cancer stem cells. , 2008, Cell stem cell.

[34]  Jennifer Y. Zhang,et al.  NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. , 2003, Nature.

[35]  Channing J Der,et al.  Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis? , 2004, Trends in cell biology.

[36]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[37]  M. Serrano,et al.  A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. , 2007, Genes & development.

[38]  E. Fuchs,et al.  Conditional ablation of beta1 integrin in skin. Severe defects in epidermal proliferation, basement membrane formation, and hair follicle invagination. , 2000, The Journal of cell biology.

[39]  L. Chin,et al.  Essential role for oncogenic Ras in tumour maintenance , 1999, Nature.

[40]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[41]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[42]  K. Siziopikou,et al.  The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies. , 2007, Breast.

[43]  D Ratner,et al.  Cutaneous squamous-cell carcinoma. , 2001, The New England journal of medicine.

[44]  E. Wayner,et al.  Regulation of human B-cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1). , 1993, Blood.

[45]  – Published , 2022 .

[46]  J. Huisman The Netherlands , 1996, The Lancet.

[47]  Joe W Gray,et al.  Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. , 2006, Cancer research.

[48]  Jeffrey T. Chang,et al.  Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.

[49]  J. Rader,et al.  Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates. , 2007, Cancer research.

[50]  F. Watt,et al.  Different consequences of beta1 integrin deletion in neonatal and adult mouse epidermis reveal a context-dependent role of integrins in regulating proliferation, differentiation, and intercellular communication. , 2005, The Journal of investigative dermatology.

[51]  P. Khavari,et al.  Epidermal Ras blockade demonstrates spatially localized Ras promotion of proliferation and inhibition of differentiation , 2002, Oncogene.

[52]  F. Watt,et al.  A tumor-associated β1 integrin mutation that abrogates epithelial differentiation control , 2003, The Journal of cell biology.

[53]  Massimo Marchiori,et al.  Error and attacktolerance of complex network s , 2004 .

[54]  G. Nolan,et al.  Transglutaminase 1 delivery to lamellar ichthyosis keratinocytes. , 1996, Human gene therapy.